New hip implant under surveillance: will it last?

NCT ID NCT02748408

Recruiting now Disease control Sponsor: Medacta International SA Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking 550 adults aged 18–75 who receive the Medacta SMS femoral stem during total hip replacement. Researchers will monitor how long the implant lasts, how well the hip functions, patient satisfaction, and quality of life. The goal is to confirm the device's safety and performance in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SMS femoral stem (a metal hip implant device)
What this could lead to: If successful, this study will confirm that the Medacta SMS hip stem is safe and effective for long-term use in hip replacement patients.
What could go wrong: This is an observational surveillance study, not a controlled trial, so results may be influenced by patient differences. Some patients may experience implant loosening, infection, or need revision surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease arthropathy avascular necrosis of femoral head, primary, 1 developmental dysplasia of the hip familial avascular necrosis of femoral head Hip Dislocation, Congenital osteoarthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHROSIS AVASCULAR NECROSIS OF THE FEMORAL HEAD CONGENITAL HIP DYSPLASIA RHEUMATOID POLYARTHRITIS TRAUMATIC ARTHRITIS

Contacts and locations

Locations

Bürgerspital Solothurn
RECRUITING

Solothurn, CH-4500, Switzerland
Herz-Jesu Krankenhaus
RECRUITING

Vienna, 1030, Austria
Istituto Ortopedico Galezzi
RECRUITING

Milan, Milan, 20161, Italy
The Elective Orthopaedic Centre (EOC)
RECRUITING

Epsom, Surrey, KT18 7EG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.